IntroductionMost common B-cell lineage lymphomas in humans originate by transformation of germinal center (GC) B cells. These include classes of non-Hodgkin lymphoma (NHL) designated follicular lymphoma (FL), diffuse large B-cell lymphoma (DLBCL), and Burkitt lymphoma (BL) as well as classical Hodgkin lymphoma. 1 FL and BL are characterized by recurring reciprocal chromosome (Chr) translocations that fuse Ig genes either with the BCL2 cell survival gene or with the MYC proto-oncogene, respectively. 2,3 Also, reciprocal Chr translocations involving the BCL6 transcriptional repressor gene and more than 20 partner loci, including the Ig genes, typify DLBCL. 4 These and additional tumor-promoting genes are subsequently expressed under the control of Ig regulatory sequences rather than their native regulatory elements, resulting in dysregulated expression. Interestingly, MYC, BCL6, and other genes, such as TCL1, are also expressed at high levels in many NHLs in the absence of activating translocations. In these cases, inappropriately high expression is a consequence of other genetic or possibly epigenetic alterations and is likely contributory to the transformation process. [5][6][7] The TCL1 proto-oncogene encodes a 14-kDa intracellular protein that associates in a multimeric complex with the serine/ threonine kinase AKT. [7][8][9][10][11] Interactions with TCL1 enhance AKT activation and, by an unknown mechanism, TCL1 stimulates the protein kinase C-mitogen-activated protein kinase-extracellular signal-related kinase (PKC-MAPK-ERK) signal transduction pathway, promoting cell survival and proliferation. 8,12,13 In human T cells, TCL1 is normally expressed only by immature cortical thymocytes and by activated peripheral T cells. 13,14 However, dysregulated expression from Chr rearrangements between TCL1 and T-cell receptor (TCR) loci results in persistent high-level expression in mature T-cell leukemia/lymphomas. 15 A direct, initiating role for heightened TCL1 expression in T-cell transformation is suggested by studies of transgenic mice with T-cell lineage-restricted TCL1 expression that develop mature T-cell leukemias following an extended premalignant phase of polyclonal expansion. 16 Despite its original identification in T-cell leukemias, TCL1 seems to have an even more prominent role in B cells and is For personal use only. on May 11, 2018. by guest www.bloodjournal.org From differentially expressed during normal B-cell maturation. Expression is robust from pre-B through follicular B-cell development, but is down-regulated during the GC reaction and is silenced in post-GC memory B and plasma cells. 17 High levels of TCL1 expression have been documented for human B-cell lymphomas originating from pre-GC and GC B cells and in AIDS-related lymphomas of post-GC cell origin. [17][18][19] The suggestion that inappropriately high expression in the GC could contribute to GC B-cell lymphomagenesis is strongly supported by studies of mice bearing a pE-B29-TCL1 transgene expressed in both T and B cells, which develop mat...